Cervical cancer is the second most common cancer worldwide with 60,000 new cases and 30,000 deaths each year in Europe alone, despite a significant progress in early diagnosis and treatment. Infection by the human papillomavirus (HPV) is accepted as the central risk factor for cervical cancer. However, it is unlikely to be the sole cause for developing cancer. Ongoing research investigates the role of specific genetic, environmental factors in determining HPV-persistence and subsequent progression of disease.
Association studies among genetic characteristics and environmental agents and virus characteristics can suggest pathogenetic mechanisms that will provide new markers of risk, diagnosis and prognosis, and possibly treatment.
The main objectives of ASSIST are to:
For further information, please visit:
http://assist.iti.gr
Project co-ordinator:
Centre for Research and Technology Hellas - Informatics and Telematics Institute (CERTH-ITI)
Partners:
Timetable: 01/06 12/08
Total cost: 4,190,946
EC funding: 2,630,000
Instrument: STREP
Project Identifier: IST-2002-027510
Microsoft in Healthcare and Life Sciences
Company Profiles:
Agfa HealthCare |
Carestream Health |
Cetrea |
CompuGroup Medical |
CSC |
CSW Group Ltd |
dbMotion |
Dell Healthcare and Life Sciences |
EMIS |
empirica |
First DataBank |
GE Healthcare |
IBM Healthcare |
Initiate Systems |
InterComponentWare AG (ICW) |
Intel in Healthcare |
InterSystems Corporation |
iPLATO Healthcare |
iSOFT |
Map of Medicine |
Oracle Healthcare Solutions |
Orion Health |
Philips Healthcare |
Picis |
SAP for Healthcare |
Siemens Healthcare |
System C Healthcare |
Telehealth Solutions |
Tieto |
Transinsight |
Toumaz |
Tunstall | ...